This Therapeutics Stock Skyrockets, Receives Major Price Target

PBLA Skyrockets in Premarket Trading: What This Means for You.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

The financial world is abuzz today as Panbela Therapeutics (PBLA) soared to a premarket high of $1.95 following a major price target upgrade to $25. This sudden surge has captured the attention of investors an…